The report "Knee Replacement Surgery Market by Procedure Type (Knee Replacement: Total, Partial, Revision), Product (Implants: Hybrid, Plastic, Metal or Ceramic; Orthobiologic, Braces), Application (Arthritis, Cancer), End User (Clinics, ASCs) - Global Forecast to 2030 " is expected to reach USD 16.17 billion by 2030 from USD 12.00 billion in 2025, at a CAGR of 6.1% from 2025 to 2030.
Browse 275 market data Tables and 58 Figures spread through 269 Pages and in-depth TOC on "Knee Replacement Surgery Market by Procedure Type (Knee Replacement: Total, Partial, Revision), Product (Implants: Hybrid, Plastic, Metal or Ceramic; Orthobiologic, Braces), Application (Arthritis, Cancer), End User (Clinics, ASCs) - Global Forecast to 2030 "
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/knee-replacement-surgery-market-246869535.html
The knee replacement surgery market is expected to witness significant growth, driven by an increasing focus on minimally invasive surgical (MIS) approaches and a rising prevalence of various orthopedic disorders such as arthritis. Key growth factors include the rising volume of both revision and primary total knee arthroplasties. Minimally invasive techniques offer numerous advantages over conventional surgical methods, such as reduced postoperative pain, expedited recovery periods, diminished lengths of hospital stays, and a lower incidence of surgical complications. These advantages are projected to significantly contribute to market expansion throughout the forecast period.
The orthobiologics segment is expected to register a significant growth rate over the forecast period.
Based on the product, the global knee replacement surgery market is segmented into knee implants, knee braces & support systems, and orthobiologics. The orthobiologics segment is expected to register significant growth over the forecast period. A growing number of patients are opting for non-surgical interventions to manage their conditions. Orthobiologics, such as Platelet-Rich Plasma (PRP) therapy, stem cell treatments, and hyaluronic acid injections, provide less invasive alternatives that enhance healing and stimulate tissue regeneration. These modalities are particularly beneficial for patients with early to moderate osteoarthritis, where conventional surgical interventions may be premature or unnecessary.
Rheumatoid arthritis & osteoarthritis are expected to register higher CAGR during the study period.
By application, the global knee replacement surgery market is segmented into osteoarthritis & rheumatoid arthritis, degenerative disease, cancer, and other applications. The Centers for Disease Control and Prevention (CDC) reports that approximately 319,000 individuals aged 65 and older are hospitalized annually in the United States due to hip fractures. Surgical intervention typically involves the use of fixation devices that stabilize the fractured bone by immobilizing it, thereby providing a protective framework that facilitates healing. The incorporation of orthobiologics into orthopedic procedures is gaining traction, as these biological agents enhance the regenerative capacity of tissues and promote faster recovery. With the increasing prevalence of conditions such as rheumatoid arthritis and osteoarthritis, coupled with a growing geriatric population, there is a projected surge in the adoption of knee surgery devices to address these joint pathologies effectively.
The hospitals segment commanded the alargest end user market share in 2024.
The end user segment of the knee replacement surgery market includes hospitals, ambulatory surgery centers, and orthopedic clinics. In 2024, hospitals accounted for the largest market share. Recent advancements in surgical technologies, anesthesia techniques, and shifts in Medicare reimbursement policies have driven an escalation in orthopedic procedures within outpatient environments, particularly ambulatory surgery centers. These developments are poised to significantly enhance the expansion of the ASC market. Consequently, we can anticipate a marked increase in the volume of knee arthroplasties conducted in these settings, thereby further propelling the growth of the ASC segment in the near future. As of 2024, prominent players in the knee replacement surgery market are Zimmer Biomet (US), Stryker (US), Johnson & Johnson, Inc. (US), Smith+Nephew PLC (UK), and B. Braun (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/